VNRX

VolitionRX Ltd · AMEX

Sector Health Technology
Industry Medical Specialties
Website volition.com
Employees(FY) 114
ISIN US9286611077

Performance

+10.8%

+0.88%

+6.44%

+2.41%

-5.73%

YTD

+2.39%

Profile

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 worldwide. It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company is based in Henderson, Nevada.

Advanced Technical Analysis

Technical Analysis of VNRX 2024-12-20

The stock exhibits a strong bullish sentiment with a Moving Average Score of 83, indicating robust upward momentum, while the Oscillators Score of 60 suggests a neutral but potentially positive trend. Overall, the combined Technical Score of 71 reinforces a favorable outlook for the stock, signaling potential for continued gains.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of VNRX

Stock Rank

Recent News & Updates

2024-12-11 19:00
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants(Prnewswire)
2024-12-09 19:00
Study shows Nu.Q Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening(Prnewswire)
2024-12-05 20:00
VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering(Prnewswire)
2024-11-15 13:02
VolitionRX Ltd (VNRX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...(Yahoo Finance)
2024-11-14 16:32
VolitionRX: Q3 Earnings Snapshot(Yahoo Finance)
2024-11-14 03:10
VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update(Prnewswire)
2024-11-13 18:19
VolitionRX Ltd (VNRX) Q3 2024 Earnings Report Preview: What to Look For(Yahoo Finance)
2024-11-07 19:00
VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update(Prnewswire)
2024-11-06 03:10
Volition Appoints Timothy I. Still as Chairman(Prnewswire)
2024-10-30 20:00
Multiple studies show Nu.Q NETs test could predict sepsis patients at risk of deteriorating(Prnewswire)
2024-10-08 20:00
Volition to share new 'NETs in sepsis management' data insights at upcoming webinar(Prnewswire)
2024-10-02 20:00
Volition hosts NETs in sepsis management symposium at ESICM Lives 2024(Prnewswire)
2024-09-30 04:10
Volition Appoints Dr. Ethel Rubin as an Independent Director(Prnewswire)
2024-09-19 20:35
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing(Yahoo Finance)
2024-09-16 00:07
Life Sciences Virtual Investor Forum Agenda Announced for September 19th(Yahoo Finance)
2024-09-10 20:00
Volition Hosts KOL Roundtable on Sepsis(Prnewswire)
2024-08-14 05:31
VolitionRX: Q2 Earnings Snapshot(Yahoo Finance)
2024-08-14 04:10
VolitionRx Limited Announces Second Quarter 2024 Financial Results and Business Update(Prnewswire)
2024-08-08 20:00
VolitionRx Announces Pricing of up to $21.5 Million Registered Direct Offering(Prnewswire)
2024-08-05 20:00
VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business Update(Prnewswire)
2024-07-08 20:30
Volition appoints PharmaVentures for Capture PCR and oncology portfolio licensing(Prnewswire)
2024-06-26 20:00
VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting(Prnewswire)
2024-06-13 21:00
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV(Accesswire)
2024-05-28 20:00
VolitionRx Limited to Present at Jefferies Global Healthcare Conference(Prnewswire)
2024-05-14 15:01
VolitionRX Ltd (VNRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances and ...(Yahoo Finance)
2024-05-13 05:11
VolitionRX: Q1 Earnings Snapshot(Yahoo Finance)
2024-05-13 04:10
VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update(Prnewswire)
2024-05-07 20:00
VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update(Prnewswire)
2024-04-22 20:00
Nu.Q Vet Cancer Test launched in-clinic in U.S. and Europe through Antech(Prnewswire)
2024-03-27 00:31
VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript(Yahoo Finance)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.